EUVIMEDEUVIMED entdecken
Multizentrische Studie

Use of Aspirin Increased the Adenoma Detection Rate and Positive Predictive Value of Fecal Immunochemical Test

Zhongxue Han iD, Ruchen Zhou, Yueyue Li iD, Yanqing Li iD

Journal of Gastroenterology and Hepatology · 2025

DOI: 10.1111/jgh.16949 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Zhongxue Han und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Aspirin, Adenoma, Colorectal Neoplasms, Occult Blood. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim We aim to evaluate the effect of aspirin on fecal immunochemical test (FIT) performance for advanced colorectal neoplasia (ACRN) including advanced adenoma (AA) and colorectal cancer (CRC).

Methods

A multicenter study involved 4887 individuals who were asked to complete a quantitative FIT and subsequent colonoscopy. Aspirin users and nonusers were matched for age and sex. The primary outcome was the positive predictive value (PPV) of FIT compared between users and matched nonusers. Univariable and multivariable logistic regression analyses were also conducted in the entire cohort and expressed as odds ratio (OR) with 95% confidence interval (CI).

Results

For AA, the PPV of FIT was 25.30% in users vs. 14.71% in nonusers ( p = 0.005), and the detection rate was 8.28% in users vs. 4.44% in nonusers ( p = 0.003). The multivariable OR after adjusting age and sex was 1.52 (95% CI, 1.02–2.22, p = 0.036) for PPV and 1.41 (95% CI, 0.99–1.99, p = 0.052) for the detection rate compared between users and nonusers. Aspirin did not affect the sensitivity and specificity of FIT for AA. Additionally, no significant difference in FIT performance for ACRN and CRC was observed.

Conclusions

The use of aspirin increased detection rate and PPV of FIT for AA, without impact on FIT performance for ACRN and CRC. Given the risk of cardiovascular events and influence on participation rate of FIT screening, aspirin withdrawal before FIT is unnecessary.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AspirinAdenomaColorectal NeoplasmsOccult BloodEarly Detection of CancerAnti-Inflammatory Agents, Non-SteroidalFecesHumansMaleFemaleMiddle AgedPredictive Value of TestsAgedColonoscopySensitivity and Specificity

Stichwörter der Autor:innen

aspirincolorectal cancer screeningfecal immunochemical testpositive predictive rate

Substanzen

AspirinAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China.

ORCID-Profile: Zhongxue Han, Yueyue Li, Yanqing Li

Zitieren

APA

Han, Z., Zhou, R., Li, Y., & Li, Y. (2025). Use of Aspirin Increased the Adenoma Detection Rate and Positive Predictive Value of Fecal Immunochemical Test. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16949

Vancouver

Han Z, Zhou R, Li Y, Li Y. Use of Aspirin Increased the Adenoma Detection Rate and Positive Predictive Value of Fecal Immunochemical Test. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.16949

BibTeX
@article{Han2025,
  author = {Han, Zhongxue and Zhou, Ruchen and Li, Yueyue and Li, Yanqing},
  title = {Use of Aspirin Increased the Adenoma Detection Rate and Positive Predictive Value of Fecal Immunochemical Test},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2025},
  doi = {10.1111/jgh.16949}
}
Kostenlos starten →